Skip to content

Clinical study of Xiaoshuan enteric-soluble capsule in the treatment of ischemic stroke

Study on the mechanism of hypoxic injury caused by cerebral ischemia and its prevention and treatment with traditional Chinese medicine

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000096
Enrollment
Unknown
Registered
2024-06-06
Start date
2021-06-01
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

treatment group:basic treatment+Xiaoshuan enteric-soluble capsule
control group:basic treatment

Sponsors

Shanxi University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients who meet the diagnosis of acute cerebral infarction and are confirmed by CT or MRI; 2. NIHSS score: 4-15 (including 4 and 15 points); 3. Patients aged between 35 and 75 years; 4. Onset time within 7 days; 5. Patients with stable vital signs, clear consciousness and no serious complications; 6. Patients with first onset or previous history of stroke without limb paralysis and other sequelae; 7. Good compliance with this study; 8. Patients or family members sign informed consent.

Exclusion criteria

Exclusion criteria: 1.In the TOAST classification, patients with cerebral infarction caused by other causes other than atherosclerosis; 2. Patients with progressive cerebral infarction or recurrent recurrent cerebral infarction; 3. Patients with severe cardiovascular diseases, liver and kidney dysfunction, and respiratory diseases; 4. Hemorrhagic disease; 5. Pregnant and lactating patients; 6.Patients who received thrombolytic therapy or mechanical thrombectomy in this hospital; 7. Patients with hearing and other dysfunction who cannot cooperate with the assessment; 8. Participated in other clinical trials within the last 90 days.

Design outcomes

Primary

MeasureTime frame
mRS;NIHSS,ADL, HIS,BI. TCM syndrome score,Western medicine efficacy scale;

Countries

China

Contacts

Public ContactFengyun Hu

Shanxi Provincial People's Hospital

fengyun71@163.com13834233638

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026